🇺🇸 FDA
Pipeline program

2-4 of the drugs listed below

R01DA010017-03

Phase 1 small_molecule completed

Quick answer

2-4 of the drugs listed below for Drug Dependence is a Phase 1 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Drug Dependence
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials